| Literature DB >> 33023159 |
Muzaffar A Khan1, Daniel Dashevsky2,3, Harald Kerkkamp1, Dušan Kordiš4, Merijn A G de Bakker1, Roel Wouters1, Jory van Thiel1,5, Bianca Op den Brouw2,6, Freek Vonk1,5,7, R Manjunatha Kini8,9, Jawad Nazir10,11, Bryan G Fry2, Michael K Richardson1.
Abstract
Venomous snakes are important subjects of study in evolution, ecology, and biomedicine. Many venomous snakes have alpha-neurotoxins (α-neurotoxins) in their venom. These toxins bind the alpha-1 nicotinic acetylcholine receptor (nAChR) at the neuromuscular junction, causing paralysis and asphyxia. Several venomous snakes and their predators have evolved resistance to α-neurotoxins. The resistance is conferred by steric hindrance from N-glycosylated asparagines at amino acids 187 or 189, by an arginine at position 187 that has been hypothesized to either electrostatically repulse positively charged neurotoxins or sterically interfere with α-neurotoxin binding, or proline replacements at positions 194 or 197 of the nAChR ligand-binding domain to inhibit α-neurotoxin binding through structural changes in the receptor. Here, we analyzed this domain in 148 vertebrate species, and assessed its amino acid sequences for resistance-associated mutations. Of these sequences, 89 were sequenced de novo. We find widespread convergent evolution of the N-glycosylation form of resistance in several taxa including venomous snakes and their lizard prey, but not in the snake-eating birds studied. We also document new lineages with the arginine form of inhibition. Using an in vivo assay in four species, we provide further evidence that N-glycosylation mutations reduce the toxicity of cobra venom. The nAChR is of crucial importance for normal neuromuscular function and is highly conserved throughout the vertebrates as a result. Our research shows that the evolution of α-neurotoxins in snakes may well have prompted arms races and mutations to this ancient receptor across a wide range of sympatric vertebrates. These findings underscore the inter-connectedness of the biosphere and the ripple effects that one adaption can have across global ecosystems.Entities:
Keywords: CHRNA1; Elapidae; N-glycosylation; evolutionary arms race; nicotinic acetylcholine receptor (nAChR); resistance; venom
Mesh:
Substances:
Year: 2020 PMID: 33023159 PMCID: PMC7601176 DOI: 10.3390/toxins12100638
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 4.546
Figure 1The ligand-binding domain of the nicotinic acetylcholine receptor (nAChR). (A) Ribbon model of α-bungarotoxin (brown) forming a complex with the ligand-binding domain (blue) on the extracellular domain of a single human α1-nAChR subunit (green). This structure is publicly available from the RCSB Protein Data Bank under the ID 6UWZ [20]. (B) Sequence logo showing the information value and amino acid content of the ligand-binding domain sequences in our dataset. Note the complete conservation of positions 190, 192, 193, 198, and 200 (blue) and strong conservation of positions 188 and 199 (teal). Logo was produced using the R ggseqlogo package [34].
Key sites and mutations that confer α-neurotoxin resistance.
| Site | Mutation | Mechanism | Reference |
|---|---|---|---|
| 187 | NXS/T | Steric | [ |
| R | Steric | [ | |
| 189 | NXS/T | Steric | [ |
| 194 | L | Proline | [ |
| S | Proline | [ | |
| 197 | H | Proline | [ |
Figure 2Sites of positive selection in α1-nAChR ligand-binding domain. Topology constructed from the consensus of TimeTree.org and taxon-specific phylogenies [43,44,45,46,47,48,49,50,51]. The most common amino acid sequence of the α1-nAChR ligand-binding is displayed for one species (Danio rerio) and differences from this sequence are displayed for all other species. Sites showing significant positive selection are highlighted in grey for the relevant clade. Green taxa and amino acids indicate resistance conferred through the glycosylated NXS/T motif, purple signifies the 187R mutation, and blue indicates resistance granted by proline subsite mutations. Scale bar indicates 100 million years of branch length. Continued in Figure 3.
Figure 3Continuation of Figure 2.
Pharmacological assays of cobra venom toxicity. Probit analysis was used to calculate the LD50 or LC50. For full details of the statistical analysis, see Supplementary File S1 and [52,53,54]. Key: LD50, LC50, lethal dose or lethal concetration, respectively, for 50% of embryos/larvae.
| Concentration of | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.03 | 0.06 | 0.12 | 0.24 | 0.48 | 0.945 | 1.89 | 3.78 | 7.7 | LD50 or LC50 mg/mL | |
| 1.87 | |||||||||||
| alive | 5 | - | - | 5 | 5 | 5 | - | - | - | 0 | |
| dead | 0 | - | - | 0 | 0 | 0 | - | - | - | 5 | |
| 0.340 | |||||||||||
| alive | 5 | - | - | 5 | 5 | 0 | - | - | - | 0 | |
| dead | 0 | - | - | 0 | 0 | 5 | - | - | - | 5 | |
| 0.673 | |||||||||||
| alive | 8 | 8 | 8 | 8 | 8 | 8 | 0 | 0 | 0 | 0 | |
| dead | 0 | 0 | 0 | 0 | 0 | 0 | 8 | 8 | 8 | 8 | |
| 0.062 | |||||||||||
| alive | 8 | 8 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| dead | 0 | 0 | 3 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | |
Figure 4Amino acids in the α1-nAChR ligand-binding domains of snakes are subject to stronger and more pervasive positive selection than other taxa. The predicted surface of the ligand-binding domain (blue residues in Figure 1) is colored according to fast unconstrained Bayesian approximation (FUBAR) β/α and mixed effects model of evolution (MEME) weighted β/α, where red and yellow denote positive selection, while blue and purple represent negative selection. This structure is publicly available from the RCSB PDB under the ID 6UWZ; see also [20].